Advertisement

Topics

Dyax Company Profile

07:14 EDT 20th September 2017 | BioPortfolio

Dyax is developing and commercializing new products for the pharmaceutical and biopharmaceutical industries. We discover and develop products using Dyax's two technology platforms:

Phage Display Binding Technology

Rapid identification of proteins, peptides and human antibodies for all applications

High throughput discovery of high affinity target-binding molecules

Greater diversity than any combinatorial chemistry method



Separations Products Platform

Chromatography systems and products sold under the Biotage™ tradename, providing timely, cost-effective solutions to the changing purification needs of the biopharmaceutical and traditional pharmaceuticals industries.

Location

300 Technology Square
Cambridge
MA
02139
United States of America

Contact

Phone: 617 225 2500
Fax: 617 225 2501
Email: thrapeutics@dyax.com


News Articles [8 Associated News Articles listed on BioPortfolio]

Dyax Corp. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15062017] Prices from USD $350

Dyax Corp. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Dyax Corp. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes busi...

Shire HAE treatment from Dyax deal clears Phase III hurdle

Shire's $6.5 Billion Dyax Bet Pays Off as Lanadelumab Wows in Phase III Study

  Life Sciences Jobs   ...

Keep In Touch: Communication Maintains Ongoing Purdue/Shionogi Pact

The private US pain specialist and Japanese pharma have partnered for more than a decade to develop novel pain candidates...   

VIDEO: The Future's Bright For Microbiome Investing, Says VC

Seventure Partners’ Eric de la Fortelle explains how the venture capitalist’s €160bn fund will prosper from the increased understanding of...    

Shire CEO Says Lanadelumab Results Vindicate Dyax Buy, M&A Strategy

Shire's CEO is savoring a personal victory after Phase III data for lanadelumab in acute HAE replicated impressive Phase Ib...   

Finance Watch: Two More US Biopharma IPOs And Two New European VC Funds

Two biopharma IPOs in the US continue streak of (mostly) positive returns; two new European VC funds launch as Irish...   

Axcella Announces the Appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., as Executive Vice President, Chief Strategy and Corporate Development Officer

Axcella, a biotechnology company pioneering transformative amino acid-based therapeutics for a range of severe diseases, announced today that Ivana Magovcevic-Liebisch, Ph.D., J.D...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Kalbitor [Dyax Corp.]

These highlights do not include all the information needed to use KALBITOR safely and effectively. See full prescribing information for KALBITOR. KALBITOR (ecallantide) Injection for subcutaneous use ...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.

Background Hereditary angioedema with C1 inhibitor deficiency is characterized by recurrent, unpredictable swelling episodes caused by uncontrolled plasma kallikrein generation and excessive bradykini...

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Dyax Corp.

Dyax is a fully integrated biopharmaceutical company focused on discovering, developing and commercializing novel biotherapeutics for unmet medical needs. Dyax utilizes its propri...

Dyax

Dyax is developing and commercializing new products for the pharmaceutical and biopharmaceutical industries. We discover and develop products using Dyax's two technology platforms: Phage Display B...

Zenyth Therapeutics Limited

Zenyth Therapeutics Limited (Zenyth) is a public listed (ASX: ZTL) Australian biotechnology company primarily focused on the development and commercialisation of antibody-based therapies in the areas ...

BioCatalyst International

BioCatalyst is a group of experienced business and scientific entrepreneurs who are focused on transitioning a scientifically validated product to an accepted product in the marketplace. BioCatalyst i...

More Information about "Dyax" on BioPortfolio

We have published hundreds of Dyax news stories on BioPortfolio along with dozens of Dyax Clinical Trials and PubMed Articles about Dyax for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dyax Companies in our database. You can also find out about relevant Dyax Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record